Education
- B.S., Chemistry, Nanjing University
- Ph.D., Biomedical Engineering, University of North Carolina at Chapel Hill
- Postdoctoral Fellow, Institute for Systems Biology, California Institute of Technology
Research Interests
The Lu Digital Pharmaceutics (DigiPharma) Laboratory aims to develop and apply stateof-the-art technologies to understand disease pathologies, and develop treatment strategies for cancer, infectious diseases, and autoimmune diseases. In particular, we are pursuing the following three directions:
Spatial Tissue Profiling: We integrate spatial omics with pharmaceutics to determine the factors that influence treatment response and develop data-driven precision cancer immunotherapies.
Single Extracellular Vesicle Analysis: We harness the rich information carried by extracellular vesicles to monitor blood-borne tissue and disease-specific signatures and develop biomimetic drug delivery technologies.
Health Monitoring Devices: We develop microfluidic devices to monitor the health and therapeutic response of patients and learn how to transition back to a healthy state.